Stephen Baxter
Stock Analyst at Wells Fargo
(2.19)
# 2,746
Out of 4,944 analysts
188
Total ratings
38.98%
Success rate
-3.72%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COR Cencora | Maintains: Overweight | $337 → $354 | $289.15 | +22.43% | 4 | Aug 13, 2025 | |
| CAH Cardinal Health | Maintains: Overweight | $183 → $185 | $146.30 | +26.45% | 8 | Aug 13, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $306 → $267 | $261.57 | +2.08% | 13 | Aug 4, 2025 | |
| MOH Molina Healthcare | Maintains: Overweight | $372 → $216 | $157.31 | +37.31% | 18 | Jul 23, 2025 | |
| CNC Centene | Downgrades: Equal-Weight | $72 → $30 | $26.17 | +14.64% | 22 | Jul 23, 2025 | |
| ELV Elevance Health | Maintains: Overweight | $478 → $400 | $292.48 | +36.76% | 11 | Jul 15, 2025 | |
| OSCR Oscar Health | Downgrades: Underweight | $16 → $10 | $14.98 | -33.24% | 11 | Jul 11, 2025 | |
| PNTG The Pennant Group | Maintains: Equal-Weight | $30 → $31 | $26.81 | +15.65% | 1 | Jun 3, 2025 | |
| MCK McKesson | Maintains: Equal-Weight | $691 → $766 | $659.01 | +16.23% | 6 | Jun 3, 2025 | |
| CYH Community Health Systems | Maintains: Underweight | $2 → $3.5 | $2.56 | +36.72% | 9 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $320 → $385 | $390.31 | -1.36% | 14 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $150 → $195 | $170.48 | +14.38% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $27 | $21.72 | +24.31% | 4 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $5 | $0.89 | +460.85% | 7 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $76 → $84 | $65.51 | +28.22% | 14 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $230 → $225 | $175.21 | +28.42% | 13 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $370 → $341 | $280.47 | +21.58% | 7 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $387 → $290 | $274.94 | +5.48% | 10 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $15 | $6.87 | +118.34% | 3 | Apr 29, 2024 |
Cencora
Aug 13, 2025
Maintains: Overweight
Price Target: $337 → $354
Current: $289.15
Upside: +22.43%
Cardinal Health
Aug 13, 2025
Maintains: Overweight
Price Target: $183 → $185
Current: $146.30
Upside: +26.45%
UnitedHealth Group
Aug 4, 2025
Maintains: Overweight
Price Target: $306 → $267
Current: $261.57
Upside: +2.08%
Molina Healthcare
Jul 23, 2025
Maintains: Overweight
Price Target: $372 → $216
Current: $157.31
Upside: +37.31%
Centene
Jul 23, 2025
Downgrades: Equal-Weight
Price Target: $72 → $30
Current: $26.17
Upside: +14.64%
Elevance Health
Jul 15, 2025
Maintains: Overweight
Price Target: $478 → $400
Current: $292.48
Upside: +36.76%
Oscar Health
Jul 11, 2025
Downgrades: Underweight
Price Target: $16 → $10
Current: $14.98
Upside: -33.24%
The Pennant Group
Jun 3, 2025
Maintains: Equal-Weight
Price Target: $30 → $31
Current: $26.81
Upside: +15.65%
McKesson
Jun 3, 2025
Maintains: Equal-Weight
Price Target: $691 → $766
Current: $659.01
Upside: +16.23%
Community Health Systems
May 29, 2025
Maintains: Underweight
Price Target: $2 → $3.5
Current: $2.56
Upside: +36.72%
May 29, 2025
Upgrades: Equal-Weight
Price Target: $320 → $385
Current: $390.31
Upside: -1.36%
May 29, 2025
Upgrades: Overweight
Price Target: $150 → $195
Current: $170.48
Upside: +14.38%
May 13, 2025
Maintains: Overweight
Price Target: $25 → $27
Current: $21.72
Upside: +24.31%
May 13, 2025
Maintains: Overweight
Price Target: $6 → $5
Current: $0.89
Upside: +460.85%
May 6, 2025
Maintains: Overweight
Price Target: $76 → $84
Current: $65.51
Upside: +28.22%
Mar 10, 2025
Maintains: Overweight
Price Target: $230 → $225
Current: $175.21
Upside: +28.42%
Feb 4, 2025
Maintains: Equal-Weight
Price Target: $370 → $341
Current: $280.47
Upside: +21.58%
Nov 4, 2024
Maintains: Overweight
Price Target: $387 → $290
Current: $274.94
Upside: +5.48%
Apr 29, 2024
Maintains: Equal-Weight
Price Target: $17 → $15
Current: $6.87
Upside: +118.34%